Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 15 IN DEXTROSE 10 AND SODIUM CHLORIDE 0 9 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 15 IN DEXTROSE 10 AND SODIUM CHLORIDE 0 9 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Potassium chloride replaces intracellular potassium, maintaining cellular membrane potential and osmolality. Dextrose provides caloric energy and rises blood glucose. Sodium chloride restores extracellular fluid volume and tonicity.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
Intravenous infusion. The rate and volume depend on the patient's fluid and electrolyte needs. Typical adult dose: 1000 mL to 2000 mL per 24 hours, providing 30-60 mEq potassium, 154 mEq sodium, 100 g dextrose, and 154 mEq chloride daily. Infusion rate not to exceed 10 mEq/hour of potassium; maximum 20 mEq/hour with continuous cardiac monitoring.
None Documented
None Documented
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Potassium: ~12 h (non-steady-state); chloride: ~8-12 h; glucose: 1.5-2.5 h. Half-life prolonged with renal impairment or hyperkalemic states.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Renal: >90% as potassium, chloride, and glucose; lesser extent fecal/ biliary. Potassium and chloride are actively reabsorbed; glucose is completely reabsorbed (up to ~180 mg/dL) from glomerular filtrate.
Category C
Category A/B
Electrolyte
Electrolyte